DELIARGYRIS EFTHYMIOS (Chief Medical Officer) received a stock award from CYTOSORBENTS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/8/2025ACC: 0001104659-25-075791
Officer· Chief Medical Officer
Since May 2020
+165K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
165K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+70K
Price / share
—
Trade value
—
% of position
17.4%
8/8/2025
403.02K→473.02K
Total
Net shares
+70K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2025 | A · Award | +70K | — | — | 17.4% | 403.02K | 473.02K |
| Total | +70K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
95K shares
Shares
+95K
Strike price
1.00
Held after
95K
Exercisable
—
8/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock95K shares | 8/8/2025 | A · Award | +95K | 1.00 | — | 95K |